Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
IsomAb Logo
IsomAb Growth Score
63
CB Rank
76732
Heat Score
58
IsomAb evaluate and develop isoform specific antibodies to treat disease.
Founded
obfuscation
PrivateSeed Nottingham, Nottingham, United Kingdom1-10 www.isomab.bio/
Overview

IsomAb
Total Funding
obfuscation
Growth Score
63
Heat Score
58

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score63
-7 pts
in past quarter
Heat Score 58
-11 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About IsomAb

CB Rank
76732
IsomAb evaluate and develop isoform specific antibodies to treat disease.
Founded
obfuscation
PrivateSeed Nottingham, Nottingham, United Kingdom1-10 www.isomab.bio/

Funding Rounds

Seed
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Key People

  • Photo of Anker Lundemose
    Anker Lundemose: Executive Chairman
    Past Role: Commit Biologics, Executive Chairman
  • Photo of Robin Pakenham
    Robin Pakenham: Chief Operating and Financial Officer
    Past Role: Kind Consumer, Chief Financial Officer

Details

Legal Name IsomAb Ltd
Operating Status Active
Company Type For Profit
Founders  David Bates, Stephen Harper
About the Company
IsomAb evaluate and develop isoform specific antibodies to treat disease.
Contact Email info@isomab.bio
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

ISM-001
A therapeutic antibody designed to neutralize the VEGF-A 165 b isoform to treat peripheral arterial disease (PAD) and chronic limb threatening ischaemia (CLTI).

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed
obfuscation
Seed Round - IsomAb Logo
Seed Round - IsomAb
3
obfuscation
Broadview VenturesSeed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
SCVC Logo
SCVC
—
Seed Round - IsomAb Logo
Seed Round - IsomAb
Harry Destecroix
SCVC Logo
SCVC
—
Seed Round - IsomAb Logo
Seed Round - IsomAb
Harry Destecroix
SCVC Logo
SCVC
—
Seed Round - IsomAb Logo
Seed Round - IsomAb
Harry Destecroix
SCVC Logo
SCVC
—
Seed Round - IsomAb Logo
Seed Round - IsomAb
Harry Destecroix
SCVC Logo
SCVC
—
Seed Round - IsomAb Logo
Seed Round - IsomAb
Harry Destecroix
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 6 Board Members and Advisors 6 Contacts 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Mar 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 25, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 21, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 10, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

234
-11.36%
 in past month

IT Spend

$273.4KThis year, IsomAb is projected to spend $273.4K on IT, according to Aberdeen.

Active Website Tech Count

3IsomAb is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 10m and  WordPress 6.6.
Sub-Organizations
Frequently Asked Questions

Where is IsomAb's headquarters? IsomAb is located in Nottingham, Nottingham, United Kingdom.Who invested in IsomAb? IsomAb has 3 investors including SCVC and  MEIF Proof-of-Concept & Early Stage Fund.When was the last funding round for IsomAb? IsomAb closed its last funding round on
obfuscation
from a Seed round.Who are IsomAb's competitors? Alternatives and possible competitors to IsomAb may include Roche, Regeneron, and  Ionis Pharmaceuticals.How much funding has IsomAb raised to date? IsomAb has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(790e229 1)
|